Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 07:55 am Sale |
2024-12-31 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 5,249,069 4.900% |
-725,647 (-12.15%) |
Filing History |
| 2024-11-14 5:30 pm Sale |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 5,974,716 5.500% |
-2,087,003 (-25.89%) |
Filing History |
| 2024-02-13 6:57 pm Purchase |
2023-12-31 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 8,061,719 11.000% |
5,121,092 (+174.15%) |
Filing History |
| 2024-02-13 6:55 pm Purchase |
2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BCLS I Investco, LP | 16,915,784 11.000% |
4,713,274 (+38.63%) |
Filing History |
| 2024-01-22 4:30 pm Sale |
2024-01-18 | 13G | Pharvaris N.V. PHVS |
BCLS I Investco, LP | 1,967,093 3.800% |
-918,173 (-31.82%) |
Filing History |
| 2023-06-23 4:34 pm Unchanged |
2023-06-21 | 13G | Pharvaris N.V. PHVS |
BCLS I Investco, LP | 2,885,266 7.100% |
0 (Unchanged) |
Filing History |
| 2023-05-30 5:00 pm Sale |
2023-05-25 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 2,940,627 5.500% |
-1,945,989 (-39.82%) |
Filing History |
| 2023-02-14 06:41 am Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 4,886,616 11.000% |
1,945,989 (+66.18%) |
Filing History |
| 2023-02-14 06:34 am Purchase |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BCLS I Investco, LP | 12,202,510 11.000% |
9,315,968 (+322.74%) |
Filing History |
| 2022-08-17 5:00 pm Sale |
2022-08-15 | 13D | Dynavax Technologies Corporation DVAX |
BCLS I Investco, LP | 4,912,610 3.900% |
-2,721,435 (-35.65%) |
Filing History |
| 2022-08-08 4:49 pm Unchanged |
2022-08-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
BCLS I Investco, LP | 2,721,436 4.500% |
0 (Unchanged) |
Filing History |
| 2022-05-27 4:19 pm Sale |
2022-05-25 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
BCLS I Investco, LP | 2,721,436 5.300% |
-888,360 (-24.61%) |
Filing History |
| 2022-02-14 06:39 am Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BCLS I Investco, LP | 2,886,542 11.000% |
1,238,057 (+75.10%) |
Filing History |
| 2022-02-14 06:37 am Purchase |
2021-12-31 | 13G | Rapid Micro Biosystems, Inc. RPID |
BCLS I Investco, LP | 7,651,369 22.200% |
7,651,369 (New Position) |
Filing History |
| 2021-08-27 5:17 pm Sale |
2021-08-27 | 13D | Dynavax Technologies Corporation DVAX |
BCLS I Investco, LP | 7,634,045 6.400% |
-2,780,955 (-26.70%) |
Filing History |
| 2021-08-11 5:16 pm Sale |
2021-08-09 | 13D | Dynavax Technologies Corporation DVAX |
BCLS I Investco, LP | 10,415,000 13.000% |
-1,356,708 (-11.53%) |
Filing History |
| 2021-06-11 5:16 pm Purchase |
2021-06-10 | 13D | Dynavax Technologies Corporation DVAX |
BCLS I Investco, LP | 11,771,708 13.000% |
875,935 (+8.04%) |
Filing History |
| 2021-03-26 4:16 pm Unchanged |
2021-03-24 | 13D | Aptinyx Inc. APTX |
BCLS I Investco, LP | 8,066,113 12.100% |
0 (Unchanged) |
Filing History |
| 2021-02-19 4:30 pm Purchase |
2021-02-09 | 13G | Pharvaris N.V. PHVS |
BCLS I Investco, LP | 2,885,266 9.100% |
2,885,266 (New Position) |
Filing History |
| 2021-02-16 3:28 pm Sale |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BCLS I Investco, LP | 1,298,178 3.600% |
-49,553 (-3.68%) |
Filing History |